Insider Transactions Reported by 22 Insiders of FATE THERAPEUTICS INC

Symbol
FATE on Nasdaq
Location
San Diego, CA

Insiders trading volume in the past year

FATE THERAPEUTICS INC executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Redmile Group, LLC Director, 10%+ Owner $45,742,159 29 May 2025
RedCo II Master Fund, L.P. Director, 10%+ Owner $12,568,673 02 Jul 2025
Bahram Valamehr President and CEO, Director $4,202,142 -$20,954 -0.5% 15 Jan 2026
J. Scott Wolchko President and CEO, Director $2,987,354 01 Feb 2024
Edward J. Dulac III Chief Financial Officer $1,948,742 04 Mar 2024
Cindy Tahl Chief Legal and Compliance Officer $1,229,355 -$20,848 -1.7% 15 Jan 2026
Jerome Charles Bressi Chief Regulatory and Quality Officer $1,202,065 15 Jan 2025
Yu-Waye Chu Chief Medical Officer $614,754 18 Apr 2023
Mark Plavsic Chief Technical Officer $540,591 10 Jan 2023
Neelufar Mozaffarian Director $218,400 29 May 2025
Powl Brian T. Chief Commercial Officer $179,808 05 Jul 2023
Yuan Xu Director $145,870 29 May 2025
Karin Jooss Director $109,200 29 May 2025
Timothy Coughlin Director $109,200 07 Jun 2024
Robert S. Epstein Director $109,200 29 May 2025
William H. Rastetter Director $109,200 29 May 2025
Michael Stewart Lee Director $109,200 29 May 2025
Robert Hershberg Director $109,200 06 Jun 2023
John Mendlein Director $109,200 29 May 2025
Shefali Agarwal Director $109,200 29 May 2025
Kamal Adawi Chief Financial Officer $98,260 15 Jan 2026
Matt Abernethy Director 29 May 2025

Recent Insider Transactions by Companies or Individuals for FATE THERAPEUTICS INC

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Cindy Tahl FATE Common Stock Award 25.8% 100,000 487,081 15 Jan 2026 Direct
Cindy Tahl FATE Stock Option (Right to Buy) Award 400,000 400,000 15 Jan 2026 Direct
Kamal Adawi FATE Common Stock Award 33.3% 25,000 100,000 15 Jan 2026 Direct
Kamal Adawi FATE Stock Option (Right to Buy) Award 75,000 75,000 15 Jan 2026 Direct
Bahram Valamehr FATE Common Stock Award 101.6% 335,000 664,708 15 Jan 2026 Direct
Bahram Valamehr FATE Stock Option (Right to Buy) Award 1,300,000 1,300,000 15 Jan 2026 Direct
Cindy Tahl FATE Common Stock Sale -2.66% $11,275 $1.06 -10,589 387,081 09 Jan 2026 Direct
Bahram Valamehr FATE Common Stock Sale -1.55% $5,557 $1.07 -5,190 329,708 09 Jan 2026 Direct
Kamal Adawi FATE Common Stock Award 75,000 75,000 20 Oct 2025 Direct
Kamal Adawi FATE Stock Option (Right to Buy) Award 375,000 375,000 20 Oct 2025 Direct
Cindy Tahl FATE Common Stock Sale -2.22% $9,573 $1.06 -9,037 397,670 04 Aug 2025 Direct
Bahram Valamehr FATE Common Stock Sale -4.14% $15,396 $1.06 -14,466 334,898 04 Aug 2025 Direct
Michael Stewart Lee FATE Stock Option (Right to Buy) Award 55,000 55,000 29 May 2025 Direct
Redmile Group, LLC FATE Stock Option (Right to Buy) Award 55,000 55,000 29 May 2025 See Footnote
Yuan Xu FATE Stock Option (Right to Buy) Award 55,000 55,000 29 May 2025 Direct
Neelufar Mozaffarian FATE Stock Option (Right to Buy) Award 55,000 55,000 29 May 2025 Direct
William H. Rastetter FATE Stock Option (Right to Buy) Award 55,000 55,000 29 May 2025 Direct
John Mendlein FATE Stock Option (Right to Buy) Award 55,000 55,000 29 May 2025 Direct
Karin Jooss FATE Stock Option (Right to Buy) Award 55,000 55,000 29 May 2025 Direct
Robert S. Epstein FATE Stock Option (Right to Buy) Award 55,000 55,000 29 May 2025 Direct
Matt Abernethy FATE Stock Option (Right to Buy) Award 110,000 110,000 29 May 2025 Direct
Shefali Agarwal FATE Stock Option (Right to Buy) Award 55,000 55,000 29 May 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.